只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 2026-07-02 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 10,176 | US$87.44 | US$889,789.44 | 587,364 | SEC |
| 2026-07-01 2026-07-02 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 4,234 | US$88.12 | US$373,100.08 | 583,130 | SEC |
| 2026-07-01 2026-07-02 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 590 | US$88.91 | US$52,456.90 | 582,540 | SEC |
| 2026-07-01 2026-07-02 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 6,500 | US$87.52 | US$568,880.00 | 1,834 | SEC |
| 2026-07-01 2026-07-02 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 1,834 | US$88.34 | US$162,015.56 | 0 | SEC |
| 2026-07-01 2026-07-02 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 5,775 | US$87.55 | US$505,601.25 | 99,719 | SEC |
| 2026-07-01 2026-07-02 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 1,725 | US$88.37 | US$152,438.25 | 97,994 | SEC |
| 2026-06-25 2026-06-26 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 5,000 | US$87.12 | US$435,600.00 | 107,994 | SEC |
| 2026-06-25 2026-06-26 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 10,000 | US$87.14 | US$871,400.00 | 97,994 | SEC |
| 2026-06-23 2026-06-23 | SYRE Spyre Therapeutics, Inc. | Fairmount Funds Management LLC Director | 卖出（S） | 4,684,781 | US$85.31 | US$4亿 | 0 | SEC |
| 2026-06-23 2026-06-23 | SYRE Spyre Therapeutics, Inc. | Kiselak Tomas Director | 卖出（S） | 4,684,781 | US$85.31 | US$4亿 | 0 | SEC |
| 2026-06-23 2026-06-23 | SYRE Spyre Therapeutics, Inc. | Fairmount Healthcare Fund II L.P. Director | 卖出（S） | 4,684,781 | US$85.31 | US$4亿 | 0 | SEC |
| 2026-06-23 2026-06-23 | SYRE Spyre Therapeutics, Inc. | Harwin Peter Evan Director | 卖出（S） | 4,684,781 | US$85.31 | US$4亿 | 0 | SEC |
| 2026-06-22 2026-06-23 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director | 卖出（S） | 20,000 | US$100.00 | US$200万 | 68,606 | SEC |
| 2026-06-03 2026-06-03 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 8,333 | US$75.00 | US$624,975.00 | 0 | SEC |
| 2026-06-01 2026-06-03 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 3,100 | US$72.06 | US$223,386.00 | 97,994 | SEC |
| 2026-06-01 2026-06-03 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 2,599 | US$70.77 | US$183,931.23 | 101,094 | SEC |
| 2026-06-01 2026-06-03 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 1,801 | US$69.75 | US$125,619.75 | 103,693 | SEC |
| 2026-06-01 2026-06-03 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 3,294 | US$71.38 | US$235,125.72 | 597,540 | SEC |
| 2026-06-01 2026-06-03 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 8,149 | US$70.50 | US$574,504.50 | 600,834 | SEC |
| 2026-06-01 2026-06-03 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 3,557 | US$69.40 | US$246,855.80 | 608,983 | SEC |
| 2026-05-08 2026-05-08 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director | 卖出（S） | 2,404 | US$72.57 | US$174,458.28 | 166,202 | SEC |
| 2026-05-08 2026-05-08 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director | 卖出（S） | 24,814 | US$74.76 | US$185.51万 | 107,875 | SEC |
| 2026-05-08 2026-05-08 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director | 卖出（S） | 19,269 | US$75.35 | US$145.19万 | 88,606 | SEC |
| 2026-05-08 2026-05-08 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS Director | 卖出（S） | 33,513 | US$73.72 | US$247.06万 | 132,689 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 3,100 | US$73.14 | US$226,734.00 | 614,540 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 1,000 | US$71.76 | US$71,760.00 | 617,640 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 3,600 | US$70.77 | US$254,772.00 | 618,640 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 5,300 | US$69.54 | US$368,562.00 | 622,240 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 300 | US$74.96 | US$22,488.00 | 612,540 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 1,700 | US$74.23 | US$126,191.00 | 612,840 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 12,500 | US$71.37 | US$892,125.00 | 97,994 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 5,059 | US$74.60 | US$377,401.40 | 400 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 10,358 | US$73.74 | US$763,798.92 | 5,459 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 12,777 | US$72.94 | US$931,954.38 | 15,817 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 8,777 | US$71.56 | US$628,082.12 | 28,594 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 19,656 | US$70.61 | US$138.79万 | 37,371 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 400 | US$75.37 | US$30,148.00 | 0 | SEC |
| 2026-05-01 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 21,306 | US$69.53 | US$148.14万 | 57,027 | SEC |
| 2026-04-01 2026-04-03 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon Officer · Chief Medical Officer | 卖出（S） | 7,958 | US$50.00 | US$397,900.00 | 0 | SEC |
| 2026-04-01 2026-04-03 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 2,656 | US$49.92 | US$132,587.52 | 627,540 | SEC |
| 2026-04-01 2026-04-03 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron Director,Officer · Chief Executive Officer | 卖出（S） | 12,344 | US$49.20 | US$607,324.80 | 630,196 | SEC |
| 2026-04-01 2026-04-03 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 6,200 | US$49.21 | US$305,102.00 | 99,294 | SEC |
| 2026-04-01 2026-04-03 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L Officer · Chief Financial Officer | 卖出（S） | 1,300 | US$49.98 | US$64,974.00 | 97,994 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| SYRE | 117,855.8112 | 0 | 210,820.3356 | 55.90% | B, Q, N |